Follow
Francisco Téllez
Francisco Téllez
Profesor Asociado de Enfermedades Infecciosas, Departamento de Medicina, Universidad de Cádiz
Verified email at uca.es
Title
Cited by
Cited by
Year
Epidemiology and clinical features of community‐acquired, healthcare‐associated and nosocomial bloodstream infections in tertiary‐care and community hospitals
J Rodríguez‐Baño, MD López‐Prieto, MM Portillo, P Retamar, C Natera, ...
Clinical Microbiology and Infection 16 (9), 1408-1413, 2010
1642010
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus–coinfected patients with compensated cirrhosis
JA Mira, A Rivero-Juárez, LF López-Cortés, JA Girón-González, F Téllez, ...
Clinical Infectious Diseases 56 (11), 1646-1653, 2013
1122013
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis
N Merchante, A Rivero‐Juárez, F Téllez, D Merino, M José Ríos‐Villegas, ...
Hepatology 56 (1), 228-238, 2012
1072012
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain
N Merchante, E Merino, J López-Aldeguer, F Jover, ...
Clinical Infectious Diseases 56 (1), 143-150, 2013
952013
Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis
JA Pineda, E Recio, Á Camacho, J Macías, C Almodóvar, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (4), 445-449, 2009
592009
Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus–infected patients with nonalcoholic fatty liver disease
J Macías, M Mancebo, D Merino, F Téllez, ML Montes-Ramírez, F Pulido, ...
Clinical Infectious Diseases 65 (6), 1012-1019, 2017
562017
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C
JA Pineda, R Nunez-Torres, F Téllez, M Mancebo, F García, N Merchante, ...
Journal of Infection 71 (5), 571-577, 2015
512015
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy
J Macías, LE Morano, F Téllez, R Granados, A Rivero-Juárez, R Palacios, ...
Journal of hepatology 71 (1), 45-51, 2019
472019
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients
J Macías, A Camacho, MA Von Wichmann, LF Lopez-Cortés, E Ortega, ...
Aids 27 (16), 2541-2549, 2013
432013
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort …
K Neukam, LE Morano-Amado, A Rivero-Juarez, M Mancebo, ...
HIV Clinical Trials 18 (3), 126-134, 2017
402017
Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort
P Retamar, MD López-Prieto, F Rodriguez-Lopez, M de Cueto, MV Garcia, ...
International Journal of Infectious Diseases 26, 83-87, 2014
362014
Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis
N Merchante, A Rivero-Juárez, F Téllez, D Merino, MJ Ríos-Villegas, ...
Aids 31 (4), 493-500, 2017
322017
Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy
J Macías, M Márquez, F Téllez, D Merino, P Jiménez-Aguilar, ...
Clinical infectious diseases 57 (10), 1401-1408, 2013
272013
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
AYM Howe, C Rodrigo, EB Cunningham, MW Douglas, J Dietz, J Grebely, ...
JHEP Reports 4 (5), 100462, 2022
262022
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
J Dietz, VC Di Maio, A de Salazar, D Merino, J Vermehren, S Paolucci, ...
Journal of Hepatology 74 (4), 801-810, 2021
242021
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in clinical practice even with previous virological failures to protease inhibitor-based regimens
LF Lopez-Cortes, MA Castano, MA Lopez-Ruz, MJ Rios-Villegas, ...
PLoS One 11 (2), e0148924, 2016
242016
Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals
J Macias, A Rivero-Juarez, K Neukam, F Tellez, D Merino, M Frias, ...
Aids 29 (15), 1927-1935, 2015
242015
Response to Pegylated Interferon plus Ribavirin among HIV/Hepatitis C Virus–coinfected patients with compensated liver cirrhosis
JA Mira, S García-Rey, A Rivero, I de los Santos-Gil, LF López-Cortés, ...
Clinical infectious diseases 55 (12), 1719-1726, 2012
232012
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
J Macías, K Neukam, J Portilla, JA Iribarren, I de Los Santos, A Rivero, ...
Journal of antimicrobial chemotherapy 66 (6), 1346-1350, 2011
232011
Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection
J Macías, R Granados, F Téllez, D Merino, M Pérez, LE Morano, ...
Journal of viral hepatitis 26 (1), 16-24, 2019
212019
The system can't perform the operation now. Try again later.
Articles 1–20